|
1
|
Shiozawa Y, Havens AM, Pienta KJ and
Taichman RS: The bone marrow niche: habitat to hematopoietic and
mesenchymal stem cells, and unwitting host to molecular parasites.
Leukemia. 22:941–950. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Foss B, Hervig T and Bruserud Ø: Connexins
are active participants of hematopoietic stem cell regulation. Stem
Cells Dev. 18:807–812. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shipley JL and Butera JN: Acute
myelogenous leukemia. Exper Hematol. 37:649–658. 2009. View Article : Google Scholar
|
|
4
|
Foss B, Ulvestad E and Bruserud Ø:
Platelet-derived growth factor (PDGF) in human acute myelogenous
leukemia: PDGF receptor expression, endogenous PDGF release and
responsiveness to exogenous PDGF isoforms by in vitro cultured
acute myelogenous leukemia blasts. Eur J Haematol. 66:365–376.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bruserud Ø: IL-4, IL-10 and IL-13 in acute
myelogenous leukemia. Cytokines Cell Mol Ther. 4:187–198.
1998.PubMed/NCBI
|
|
6
|
Foss B, Mentzoni L and Bruserud Ø: Effects
of vascular endothelial growth factor on acute myelogenous leukemia
blasts. J Hematother Stem Cell Res. 10:81–93. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ryningen A, Wergeland L, Glenjen N,
Gjertsen BT and Bruserud Ø: In vitro crosstalk between fibroblasts
and native human acute myelogenous leukemia (AML) blasts via local
cytokine networks results in increased proliferation and decreased
apoptosis of AML cells as well as increased levels of proangiogenic
Interleukin 8. Leuk Res. 29:185–196. 2005. View Article : Google Scholar
|
|
8
|
Hatfield K, Ryningen A, Corbascio M and
Bruserud Ø: Microvascular endothelial cells increase proliferation
and inhibit apoptosis of native human acute myelogenous leukemia
blasts. Int J Cancer. 119:2313–2321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruserud Ø, Ryningen A, Wergeland L,
Glenjen NI and Gjertsen BT: Osteoblasts increase proliferation and
release of proangiogenic interleukin 8 by native human acute
myelogenous leukemia blasts. Haematologica. 89:391–402.
2004.PubMed/NCBI
|
|
10
|
Konopleva M, Konoplev S, Hu W, Zaritskey
AY, Afanasiev BV and Andreeff M: Stromal cells prevent apoptosis of
AML cells by up-regulation of anti-apoptotic proteins. Leukemia.
16:1713–1724. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Foss B, Tronstad KJ and Bruserud Ø:
Connexin-based signaling in acute myelogenous leukemia (AML).
Biochim Biophys Acta. 1798:1–8. 2010. View Article : Google Scholar
|
|
12
|
Weber MC and Tykocinski ML: Bone marrow
stromal cell blockade of human leukemic cell differentiation.
Blood. 83:2221–2229. 1994.PubMed/NCBI
|
|
13
|
Paraguassú-Braga FH, Borojevic R, Bouzas
LF, Barcinski MA and Bonomo A: Bone marrow stroma inhibits
proliferation and apoptosis in leukemic cells through gap
junction-mediated cell communication. Cell Death Differ.
10:1101–1108. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Xu Y-B, Wang Q, et al: Leukemogenic
AML1-ETO fusion protein upregulates expression of connexin 43: the
role in AML1-ETO-induced growth arrest in leukemic cells. J Cell
Physiol. 208:594–601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krenacs T and Rosendaal M: Connexin43 gap
junctions in normal, regenerating, and cultured mouse bone marrow
and in human leukemias: their possible involvement in blood
formation. Am J Pathol. 152:993–1004. 1998.PubMed/NCBI
|
|
16
|
Yi S, Chen Y, Wen L, Yang L and Cui G:
Expression of connexin 32 and connexin 43 in acute myeloid leukemia
and their roles in proliferation. Oncol Lett. 4:1003–1007.
2012.PubMed/NCBI
|
|
17
|
Liu Y, Zhang X, Li ZJ and Chen XH:
Up-regulation of Cx43 expression and GJIC function in acute
leukemia bone marrow stromal cells post-chemotherapy. Leuk Res.
34:631–640. 2010. View Article : Google Scholar
|
|
18
|
Bruserud Ø, Hovland R, Wergeland L, Huang
TS and Gjertsen BT: Flt3-mediated signaling in human acute
myelogenous leukemia (AML) blasts: a functional characterization of
Flt3-ligand effects in AML cell populations with and without
genetic Flt3 abnormalities. Haematologica. 88:416–428.
2003.PubMed/NCBI
|
|
19
|
Hatfield KJ, Hovland R, Øyan AM, et al:
Release of angio-poietin-1 by primary human acute myelogenous
leukemia cells is associated with mutations of nucleophosmin,
increased by bone marrow stromal cells and possibly antagonized by
high systemic angiopoietin-2 levels. Leukemia. 22:287–293. 2008.
View Article : Google Scholar
|
|
20
|
Tsykunova G, Reikvam H, Hovland R and
Bruserud Ø: The surface molecule signature of primary human acute
myeloid leukemia (AML) cells is highly associated with NPM1
mutation status. Leukemia. 26:557–559. 2012. View Article : Google Scholar
|
|
21
|
Bruserud Ø: Effect of dipyridamole,
theophyllamine and verapamil on spontaneous in vitro proliferation
of myelogenous leukaemia cells. Acta Oncol. 31:53–58. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dysvik B and Jonassen I: J-Express:
exploring gene expression data using Java. Bioinformatics.
17:369–370. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stavrum AK, Petersen K, Jonassen I and
Dysvik B: Analysis of gene-expression data using J-Express. Curr
Protoc Bioinformatics. Chapter 7: Unit 7.3. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
VanSlyke JK and Musil LS: Cytosolic stress
reduces degradation of connexin43 internalized from the cell
surface and enhances gap junction formation and function. Mol Biol
Cell. 16:5247–5257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hirabayashi Y, Yoon BI, Tsuboi I, et al:
Protective role of connexin 32 in steady-state hematopoiesis,
regeneration state, and leukemogenesis. Exp Biol Med. 232:700–712.
2007.
|
|
26
|
Döhner H, Estey EH, Amadori S, et al:
Diagnosis and management of acute myeloid leukemia in adults:
recommendations from an international expert panel, on behalf of
the European LeukemiaNet. Blood. 115:453–474. 2010. View Article : Google Scholar
|
|
27
|
Dürig J, Rosenthal C, Halfmeyer K, et al:
Intercellular communication between bone marrow stromal cells and
CD34+ haematopoietic progenitor cells is mediated by
connexin 43-type gap junctions. Br J Haematol. 111:416–425. 2000.
View Article : Google Scholar
|
|
28
|
Montecino-Rodriguez E, Leathers H and
Dorshkind K: Expression of connexin 43 (Cx43) is critical for
normal hematopoiesis. Blood. 96:917–924. 2000.PubMed/NCBI
|
|
29
|
Presley CA, Lee AW, Kastl B, et al: Bone
marrow connexin-43 expression is critical for hematopoietic
regeneration after chemotherapy. Cell Commun Adhes. 12:307–317.
2005. View Article : Google Scholar
|
|
30
|
Wong RC, Pébay A, Nguyen LT, Koh KL and
Pera MF: Presence of functional gap junctions in human embryonic
stem cells. Stem Cells. 22:883–889. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huettner JE, Lu A, Qu Y, Wu Y, Kim M and
McDonald JW: Gap junctions and connexon hemichannels in human
embryonic stem cells. Stem Cells. 24:1654–1667. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wörsdörfer P, Maxeiner S, Markopoulos C,
et al: Connexin expression and functional analysis of gap
junctional communication in mouse embryonic stem cells. Stem Cells.
26:431–439. 2008. View Article : Google Scholar
|
|
33
|
Wong CW, Christen T, Roth I, et al:
Connexin37 protects against atherosclerosis by regulating monocyte
adhesion. Nat Med. 12:950–954. 2006. View
Article : Google Scholar : PubMed/NCBI
|
